Print this
E-mail thisConstitution
“The Society” means the European Society for Developmental, Perinatal and Paediatric Pharmacology. “The Council” means the Members for the time being of the Executive Committee hereby constituted.
“Developmental Pharmacology” means the study of the effects and interactions of pharmacological agents upon the growth and development of the organism, in the pre- and post-conceptional, and pre- and post birth states.
“He” may be read throughout the Constitution as “he or she”.
1. NAME
The Society shall be known as “the European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDP)”.2. PURPOSE
The object of the Society shall be the promotion of developmental pharmacology, whether fetal, perinatal or paediatric, in any matter appropriate to the purpose.3. MEMBERSHIP
a) The Society shall consist of Full and Corresponding Members. The acceptance of membership shall be deemed to imply an agreement to be bound by all the Regulations of the Society for the time being.
b) Full membership is open to scientific workers who are citizens of Europe and neighbouring Mediterranean countries and either have been or are engaged in basic or clinical research connected with developmental, perinatal and paediatric pharmacology. Acceptable evidence of such interest may include published work in scientific journals or communications to learned societies concerning any aspect of developmental, perinatal and paediatric pharmacology.
c) Candidates for Membership must be proposed by two members of the Society. Nomination forms may be submitted to the General Secretary at any time, having details of the candidate’s name and qualifications for membership. New members shall ordinarily be elected following scrutiny and acceptance of the completed application by the Council. Candidate details are communicated to the Council and if no objections are raised within 4 weeks time the candidate is elected. A list of Members elected in each biennium shall be supplied to the Membership at the next Scientific Meeting. Members enjoy full voting rights at the General Meeting. Fullembers are eligible for election to the Council.
d) There shall be a category of Corresponding Membership open to citizens of countries outside Europe and neighbouring Mediterranean countries, who either have been or are engaged in basic or clinical research connected with developmental, perinatal and paediatric pharmacology, and who wish to attend one or more meetings of the Society. The nomination procedure is identical to that for full members (3 c). Corresponding Members shall have the rights of Full Members, except that they shall not be eligible for Council Membership.
e) Each Member shall pay an annual subscription, the amount thereof to be determined from time to time by the Members of the Society at the General Meeting. Membership subscriptions are due every year following receipt of an invoice from the Treasurer. Paid membership includes subscription to the Society’s official journal “Paediatric and Perinatal Drug Therapy”.
f) Any Member whose subscription is two years in arrears, and who has been sent a notification in writing of the fact by the Treasurer, shall cease to be a member of the Society.>
g) Honorary membership may be offered by the Council to individuals that have made significant contributions to the field of interest of the Society.
4. MEETINGS
4.1) Scientific
a) The Society shall hold a scientific meeting biennially for the presentation and discussion of papers by members and their guests at a time and place to be decided by its Council.
b) The programme shall be arranged by the President in collaboration with the Secretary General, the Council and the local organising committee.
c) An objective of the Society is to encourage the inclusion of recent and not necessarily completed research work at the Scientific Meeting. A summary of each paper shall be submitted in English. Copies of the summaries will be distributed at the meeting.
4.2) General
d) A General Meeting of members will be held at the time of the Scientific Meeting.
e) The Council of the Society shall meet annually. In the years of a General Meeting, the Council shall meet at the Meeting.
f) The Secretary General (or the President) shall be Chairman of all meetings of the Society and the Council. If the Secretary General and the President shall be absent from a meeting, they shall propose a Chairman for that meeting.
g) It shall be a duty of the Treasurer to present the true and audited accounts of the Society to the Society at each General Meeting. Copies of the accounts shall be made available at the Meeting to all Members, and on request to Members unable to attend the General Meeting.
h) Other meetings of the Society or of the Council may be convened.
5. LANGUAGE
The official language of the Society shall be English at meetings and in correspondence.6. COUNCIL
The Council of the Society shall consist of the President, the Past President, the President-Elect, the Secretary General, the Treasurer, and four Councillors, of whom not more than two shall live in any one country. There shall at all times be at least two persons clinically qualified and two persons qualified in other scientific disciplines on the Council. Two Councillors shall be elected biennially by the members to serve for a period of four years, beginning on the day subsequent to the General Meeting at which they are elected. A candidate for Council may (with their written consent) be proposed in writing to the Secretary General by any two members, not less than one month before the General Meeting, or by the Council. In the event of more candidates being proposed than are required, election will be by secret ballot of members at the General Meeting.Having served for four years, no ordinary member of Council shall be eligible for re‑election as an officer or other member of Council until after a lapse of two years. The Secretary General shall be eligible after four years for re‑election for one further two‑year term of office, after which they shall not be eligible for re-election as an officer or Council member of the Society until after a lapse of two years. The Treasurer shall normally serve for a period of six years, and shall be eligible for re‑election thereafter. The President will, de facto, serve on the Council for a total of six years (two years as President‑Elect, two years as President, two years as immediate Past‑President) after which they shall not be eligible for re‑election as an officer or Council member of the Society until after a lapse of two years.
The Council may, at its discretion, co‑opt other member(s) to serve in an advisory capacity, without voting rights, for such periods as may deemed necessary.
